Virax Biolabs Group Limited VRAX 深 沪
等待开盘 07-30 09:30:00 美东时间
0.9269
-0.026
-2.73%
华盛通- 最 高0.9915
- 今 开0.985
- 成交量 3.55万股
- 最 低 0.92
- 昨 收 0.9529
- 总市值 402.46万
- 52周最高 8.9999
- 市盈率 静 --
- 换手率 0.82%
- 52周最低 0.7387
- 委 比 45.60%
- 总股本 434.20万
- 历史最高 290.00
- 量 比 0.18
- 振 幅 7.50%
- 历史最低 0.60
- 每 手 1
- 风险率 1.00%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多What's Driving the Market Sentiment Around Virax Biolabs Group?
Virax Biolabs Group's (NYSE:VRAX) short percent of float has fallen 57.85% sinc...
07-01 01:00
World Health Organization Says MPOX Remains A Public Health Emergency Of International Concern
https://www.who.int/news/item/09-06-2025-fourth-meeting-of-the-international-health-regulations-(2005)-emergency-committee-regarding-the-upsurge-of-mpox-2024-temporary-recommendations
06-09 22:22
FibroBiologics announces CFO appointment
FibroBiologics (NASDAQ:FBLG) announced the appointment of Jason D. Davis, CPA, as chief financial officer, effective immediately. Davis most recently served as CFO of Virax Biolabs (VRAX). FBLG shar...
06-09 20:42
美股大行评级 | 潜在涨幅778.38%！HC Wainwright & Co.上调BioLine Rx目标价至26美元，维持"买入"评级
<span> <meta content="no-referrer" name="referrer"></span><p>https://static-hk.hstong.com/public/forum-v2/status/icon/50267976/originalpic/1113752959213998081.png</p><span style="color:#999999;">编者按：每日追踪华尔街最新评级与目标价，挖掘潜力股投资机会。</span><blockquote> <p><span style="color:#fa1432;"><strong>今日重点评级关注</strong></span></p></blockquote><p>• HC Wainwright & Co.：维持BioLine Rx(BLRX)"买入"评级，目标价从9美元升至26美元</p> <p>• 德银：上调固特异轮胎橡胶(GT)评级至"买入"，目标价13美元</p> <p
04-01 09:48
Virax Biolabs Launches Clinical Study on T Cell Dysfunction
The latest update is out from Virax Biolabs Group Ltd. Class A ( ($VRAX) ). On ...
03-18 20:28
Virax Biolabs Highlights T-Cell Dysfunction in Post-Infection Syndromes
An announcement from Virax Biolabs Group Ltd. Class A ( ($VRAX) ) is now availa...
03-13 20:27
WHO maintains public health emergency alert on mpox
The World Health Organization said it still considers mpox to be a public health emergency of international concern, its most serious classification for health alerts. The current public health emerge...
02-28 00:21
Cosmos Health announces distribution agreement with Virax Biolabs
Cosmos Health (NASDAQ:COSM) has entered into a distribution agreement with Virax Biolabs Group Limited (NASDAQ:VRAX) to distribute Virax-branded Avian Influenza Virus real-time PCR kits across various...
01-13 22:55
Virax Biolabs Announces Strategic Goals and Developments for 2025
An announcement from Virax Biolabs Group Ltd. Class A ( ($VRAX) ) is now availa...
2024-12-17 21:57
Virax Biolabs' CEO James Foster Issues Letter to Shareholders
LONDON, Dec. 17, 2024 /PRNewswire/ -- Virax Biolabs Group Limited (NASDAQ: VRAX...
2024-12-17 20:30
